Volume 21, Number 11—November 2015
Dispatch
Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
Table 1
Characteristic | Overall | January 2014 | August 2014 | p value† |
---|---|---|---|---|
Total no. enrolled | 974 | 455 | 519 | |
Age, median (IQR) |
2.5 (0.9–5.1) |
1.9 (0.9–4.1) |
2.9 (1.1–6.0) |
<0.001 |
Age category, no. (%) | ||||
1–11 mo | 262 (26.9) | 142 (31.2) | 120 (23.1) | 0.005 |
12–59 mo | 459 (47.1) | 231 (50.8) | 228 (43.9) | 0.03 |
5–15 y |
253 (26.0) |
82 (18.0) |
171 (33.0) |
<0.001 |
Male sex, no. (%) |
499 (51.2) |
241 (53.0) |
258 (49.7) |
0.3 |
Reason for outpatient visit, no. (%) | ||||
Upper respiratory tract infection | 794 (81.5) | 394 (86.6) | 400 (77.1) | <0.001 |
Gastroenteritis | 92 (9.5) | 47 (10.3) | 45 (8.7) | 0.4 |
Other |
88 (9.0) |
14 (3.1) |
74 (14.2) |
<0.001 |
Antimicrobial drug use in preceding month, no. (%)‡ |
453/967 (46.8) |
149/453 (32.9) |
175/514 (34.0) |
0.7 |
Household size, median (IQR) | 5 (4–6) | 5 (4–7) | 5 (4–6) | 0.01 |
Other children <5 y of age in household, no. (%) | 841/973 (86.4) | 422/454 (93.0) | 419 (80.7) | <0.001 |
Attendance at school or daycare, no. (%) | 293/973 (30.1) | 105/454 (23.1) | 188 (36.2) | <0.001 |
*Weather conditions were cool and dry in January and hot and wet in August. Where data were missing, an alternate denominator is included in the affected cell. IQR, interquartile range.
†For proportions, comparisons were made by using the χ2 test. For continuous variables, comparisons were made by using the Wilcoxon rank-sum test.
‡Includes definite and possible (unknown systemic medication) consumption in the community before outpatient visit.
Page created: November 18, 2015
Page updated: November 18, 2015
Page reviewed: November 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.